XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Net (Loss) Income Per Share
 9 Months Ended
Sep. 30, 2025
Net (Loss) Income Per Share [Abstract]  
Net (Loss) Income Per Share

Note 15 — Net (Loss) Income Per Share

 

Net (loss) income per share calculations for all periods have been adjusted to reflect the Company’s reverse stock splits. Net (loss) income per share was calculated based on the weighted-average number of shares of the Company’s Common Stock outstanding.

 

Basic net (loss) income per share is calculated using the weighted-average number of shares of Common Stock outstanding during the periods. Diluted net (loss) income per share is computed by giving effect to all potential shares of Common Stock, including the reflection of as-converted convertible notes, outstanding stock options, stock related to unvested restricted stock units, and outstanding warrants to the extent dilutive. Net (loss) income per share, assuming dilution, is equal to basic net (loss) income per share for the three and nine months ended September 30, 2025 and 2024 because the effect of dilutive securities outstanding during the periods, including convertible notes, options, restricted stock units and warrants computed using the treasury stock method, is anti-dilutive.

 

The components of basic and diluted net loss per share were as follows:

 

   Three months ended September 30,   Nine months ended September 30, 
(In thousands, except share and per share data)  2025   2024   2025   2024 
Numerator:                
Net loss from continuing operations  $(10,633)  $(16,356)  $(21,112)  $(17,283)
Net (loss) income from discontinued operations   (32)   (2,295)   1,461    (104)
Numerator for basic EPS - net loss available for common shareholders  $(10,665)  $(18,651)  $(19,651)  $(17,387)
Denominator:                    
Denominator for basic EPS - Weighted-average common shares outstanding   2,002,568    1,079,198    1,973,553    828,344 
Net loss per share attributable to common shareholders - basic and diluted  $(5.33)  $(17.28)  $(9.96)  $(20.99)

For each of the periods presented, the Company’s potential dilutive securities, which include stock options, restricted stock units, and warrants, and convertible notes, have been excluded from the computation of basic and diluted net (loss) income per share. The Convertible Notes outstanding during the nine months ended September 30, 2025 were also excluded from the computation of diluted net (loss) per share as they do not represent common stock equivalents unless and until conversion conditions are met. The weighted-average number of shares of Common Stock outstanding used to calculate both basic and diluted net loss per share attributable to Common Stockholders is the same. The Company excluded the following potential Common Stock equivalents presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to Common stockholders for the periods indicated because including them would have had an anti-dilutive effect: 

 

   Nine months ended
September 30,		 
   2025   2024 
Shares subject to outstanding warrants   7,641,863    154,149 
Shares subject to unvested restricted stock units   82,000    136,880 
Shares subject to outstanding stock options   75    651 
    7,723,938    291,680